title: Peptide triazole inactivators of HIV-1: how do they work and what is their potential?
authors.affiliation: Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
authors.forename: Irwin
authors.initials: I
authors.lastname: Chaiken
authors.affiliation: Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
authors.forename: Adel A
authors.initials: AA
authors.lastname: Rashad
mesh_terms: D019380:Anti-HIV Agents / Q000737:chemistry* / Q000494:pharmacology; D002384:Catalysis; D003300:Copper / Q000737:chemistry; D061565:Cycloaddition Reaction; D015699:HIV Envelope Protein gp120 / Q000037:antagonists & inhibitors / Q000378:metabolism; D015497:HIV-1 / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D010455:Peptides / Q000737:chemistry*; D014230:Triazoles / Q000737:chemistry*; D053586:Virus Internalization / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D015699:HIV Envelope Protein gp120; D010455:Peptides; D014230:Triazoles; D003300:Copper
keywords: AIDS; HIV-1; cell entry; envelope protein antagonism; infection inhibition; macrocycle; peptidomimetics; virus inactivation